
    
      This is an interventional study involving patients that have a diagnosis of chronic kidney
      disease. Patients will have at least stage 3 chronic kidney disease stage or greater.
      Kidney-derived endothelial progenitor cells will have been obtained using associated
      protocols that are currently approved by the Partners Human Research Committee.
    
  